Rani Therapeutics Holdings Inc Share Price

NASDAQ: RANI

Small Cap

$0.50

-0.01

(-1.01%)

as on September 13, 2025 at 1:29 am IST

$₹

Rani Therapeutics Holdings Inc Stock Performance

as on September 13, 2025 at 1:29 am IST

Day's Low
Day's High
$0.49
Day's Price Range
$0.51
$0.5
2.00%
Downside
2.00%
Upside
52 Week's Low
52 Week's High
$0.39
52-Week Price Range
$3.75
$0.5
22.60%
Downside
650.00%
Upside

Rani Therapeutics Holdings Inc share price movements today

Previous Close: $0.50
Open: $0.49
Volume: 649.4K
Day's Low - High: $0.49 - $0.51
52 Week Low - High: $0.39 - $3.75

Rani Therapeutics Holdings Inc Historical Returns

1 Month Return: -5.38 %
3 Month Return: -4.89 %
1 Year Return: -78.92 %
3 Year Return: -94.76 %
5 Year Return: 0 %

Rani Therapeutics Holdings Inc Stock Fundamentals & Key Indicators

Check Rani Therapeutics Holdings Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$35.5M

EPS (TTM)

-0.54

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

P/B Ratio

PEG Ratio

EBITDA

-44.5M

Revenue (TTM)

1.2M

Profit Margin

0.00%

Return On Equity TTM

0.00%

Rani Therapeutics Holdings Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Rani Therapeutics Holdings Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Rani Therapeutics Holdings Inc	BUY	$35.5M	NA	NA	0.00%
Alnylam Pharmaceuticals, Inc.	BUY	$61.1B	280.5%	-505.15	-12.96%
Beone Medicines Ltd	NA	$37.7B	NA	NA	-3.89%
Vertex Pharmaceuticals Incorporated	BUY	$101.2B	54.04%	28.08	31.86%
Regeneron Pharmaceuticals, Inc.	BUY	$59.4B	2.03%	14.11	31.37%

Stock Returns calculator for Rani Therapeutics Holdings Inc Stock including INR - Dollar returns

The Rani Therapeutics Holdings Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Rani Therapeutics Holdings Inc investment value today

Current value as on today

₹26,236

Returns

₹73,764

(-73.76%)

Returns from Rani Therapeutics Holdings Inc Stock

₹78,903 (-78.9%)

Dollar Returns*

₹5,139 (+5.14%)

Analyst Recommendation on Rani Therapeutics Holdings Inc Stock

Based on 13 analysts

BUY

92.31%

Buy

7.69%

Hold

0.00%

Sell

Based on 13 analysts, 92.31% of analysts recommend a 'BUY' rating for Rani Therapeutics Holdings Inc. Average target price of $7.75

Rani Therapeutics Holdings Inc Share Price Target

Get share price movements and forecasts by analysts on Rani Therapeutics Holdings Inc.

What analysts predicted

93.55%UPSIDE

Target Price

$7.75

Current Price

$0.5

Analyzed by

13 Analysts

Target

$7.75

Rani Therapeutics Holdings Inc target price $7.75, a slight upside of 93.55% compared to current price of $0.5. According to 13 analysts rating.

Rani Therapeutics Holdings Inc Stock's Interest Amongst Investors

Search interest for Rani Therapeutics Holdings Inc Stock has decreased by -60% in the last 30 days, reflecting a downward trend in search activity.

Time period: August 16, 2025 to September 15, 2025

Change:-60% versus previous 30 day period

Rani Therapeutics Holdings Inc Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Total Revenue	-	-	-	2	-	-	-	1	0	-
Gross Profit	0	0	0	2	0	0	0	1	0	0
Operating Income	-16	-18	-17	-13	-14	-12	-11	-14	-12	-10
EBITDA	-15	-16	-16	-12	-13	-11	-11	-14	-12	-10
Interest Expense	1	1	1	1	1	1	1	1	0	0
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-16	-18	-18	-14	-14	-13	-12	-15	-7	-6
Income Tax Expense	-8	-9	-9	-6	-7	-6	-	-	-	-
Net Income	-8	-9	-9	-7	-7	-6	-6	-8	-7	-6
Net Profit Margin	0.00%	0.00%	0.00%	-258.11%	0.00%	0.00%	0.00%	-870.33%	-4223.26%	0.00%

Rani Therapeutics Holdings Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	0	0	2	-	-	1
Gross Profit	0	0	2	-1	0	1
Operating Income	-27	-16	-51	-63	-66	-53
EBITDA	-26	-15	-52	-60	-65	-50
Interest Expense	0	0	0	1	5	5
Depreciation	0	0	0	0	0	1
Income Before Tax	-26	-16	-53	-63	-67	-30
Income Tax Expense	0	0	0	0	-33	26
Net Income	-26	-16	-8	-63	-33	-30
Net Profit Margin	-2716.75%	-3615.37%	-306.62%	0.00%	0.00%	-2920.04%

Rani Therapeutics Holdings Inc Quarterly Cash Flow

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Net Income	-18	-18	-7	-7	-6	-12	-15	-7	-11
Operating Cash Flow	-12	-14	-12	-9	-9	-8	-8	-8	-5
Investing Cash Flow	0	11	13	10	6	0	2	18	5
Financing Cash Flow	0	0	0	0	0	7	5	-3	0
Change in Cash	-11	-2	0	1	-2	0	0	6	0

Rani Therapeutics Holdings Inc Annual Cash Flow

All numbers in Millions USD

	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	-16	-8	-63	-33	-56
Operating Cash Flow	-14	-32	-46	-51	-35
Investing Cash Flow	-1	0	-72	29	19
Financing Cash Flow	72	77	29	0	13
Change in Cash	56	44	-89	-21	-2

Global Institutional Holdings in Rani Therapeutics Holdings Inc

Funds	Holdings
Vanguard Group Inc	1.83%
United Services Automobile Association	0.69%
Takeda Pharmaceutical Co Ltd	0.47%
Geode Capital Management, LLC	0.45%
KESTRA PRIVATE WEALTH SERVICES, LLC	0.32%

See all

Insights on Rani Therapeutics Holdings Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 75.7% return, outperforming this stock by 154.8%
NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 123.5% return, outperforming this stock by 218.1%
NEGATIVE IMPACT
Price Dip
In the last 6 months, RANI stock has moved down by -67.2%

About Rani Therapeutics Holdings Inc

Rani Therapeutics is a clinical-stage biotech company that has developed a platform technology to enable oral delivery of biologic drugs.

Organisation	Rani Therapeutics Holdings Inc
Headquarters	2051 Ringwood Avenue, San Jose, CA, United States, 95131
CEO	Mr. Talat Imran
E-voting on shares	Click here to vote

Key Management of Rani Therapeutics Holdings Inc

Name	Title
Mr. Svai S. Sanford	Chief Financial Officer
Dr. Mir Hashim	Chief Scientific Officer
Mr. Alireza Javadi	Vice President of Technical Operations
Ms. Kate McKinley M.B.A.	Chief Business Officer
Ms. Arvinder Dhalla	Vice President of Clinical Development
Mr. Mir A. Imran	Executive Chairman
Mr. Talat Imran	CEO & Director
Ms. Bella Vazquez	Vice President of Human Resources
Ms. Betsy Gutierrez	Senior Vice President of Quality Assurance

FAQs

What is Rani Therapeutics Holdings Inc share price today?

Rani Therapeutics Holdings Inc share price today is $0.5 as on September 13, 2025 at 1:29 am IST at the close of the market. Rani Therapeutics Holdings Inc share today touched a day high of $0.51 and a low of $0.49.

What is the 52 week high and 52 week low for Rani Therapeutics Holdings Inc share?

Rani Therapeutics Holdings Inc share touched a 52 week high of $3.75 on October 15, 2024 and a 52 week low of $0.39 on July 15, 2025. Rani Therapeutics Holdings Inc stock price today i.e. September 13, 2025 at 1:29 am IST is closed at $0.5,which is 86.67% down from its 52 week high and 29.20% up from its 52 week low.

What is Rani Therapeutics Holdings Inc's market capitalisation today?

Rani Therapeutics Holdings Inc market capitalisation is $0.00T as on September 13, 2025 at 1:29 am IST.

How to invest in Rani Therapeutics Holdings Inc Stock (RANI) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Rani Therapeutics Holdings Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Rani Therapeutics Holdings Inc Shares that will get you 3.0000 shares as per Rani Therapeutics Holdings Inc share price of $0.5 per share as on September 13, 2025 at 1:29 am IST.

What is the minimum amount required to buy Rani Therapeutics Holdings Inc Stock (RANI) from India?

Indian investors can start investing in Rani Therapeutics Holdings Inc (RANI) shares with as little as ₹88.27 or $1 (as of September 15, 2025 at 11:42 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹882.70 in Rani Therapeutics Holdings Inc stock (as per the Rupee-Dollar exchange rate as on September 15, 2025 at 11:42 am IST). Based on Rani Therapeutics Holdings Inc share’s latest price of $0.5 as on September 13, 2025 at 1:29 am IST, you will get 20.0000 shares of Rani Therapeutics Holdings Inc. Learn more about fractional shares .